View source for FP + Surgery +/- FP

== Indication ==
Perioperative chemotherapy for resectable adenocarcinoma of esophagogastric junction and lower esophagus

*5-FU 800 mg/m2/d civi d1-5
*Cisplatin 100 mg/m2 iv over 1 h d1 or d2
*Q4w x 2-3 cycles 
*Surgery 4-6 weeks after chemotherapy
4-6 weeks after surgery, repeat the chemotherapy if response to preoperative chemotherapy or stable disease with pN+:
*5-FU 800 mg/m2/d civi d1-5
*Cisplatin 100 mg/m2 iv over 1 h d1 or d2
*Q4w x 3-4 cycles

== References ==
[http://www.asco.org/portal/site/ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid=76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abst_detail_view&confID=47&abstractID=33499&CookiesSet=1 Boige V et al. Final results of a randomized trial comparing preoperative 5-fluorouracil  (F) / cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. 2007 ASCO annual meeting. Abstract 4510]